Dr. Resora P. Acoba, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 400 S Pinetree Blvd., Patient Billing Dept, Thomasville, GA 31792 Phone: 229-227-2977 Fax: 229-227-2955 |
William R Kelso Ii, M.D, General Practice Medicare: Not Enrolled in Medicare Practice Location: 454 Smith Ave, Thomasville, GA 31792 Phone: 229-227-5510 Fax: 229-227-5527 |
News Archive
Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University and the Pere Virgili Health Park.
By altering a molecule called Stat1, which is involved in cellular immune signaling, scientists have succeeded in making the molecule more responsive and thus more efficient. This old protein with a new twist may eventually be used to improve the body's defense against infection.
Zealand Pharma A/S, the biopharmaceutical company dedicated to the discovery and development of innovative peptide-based drugs, is pleased to note that its partner, sanofi-aventis, has today announced positive top-line results of the Phase III GETGOAL-L-ASIA trial which assessed the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist discovered by Zealand Pharma, in combination with basal insulin.
Research conducted by Dr. Jayne S. Weiss, Professor and Chair of Ophthalmology at LSU Health Sciences Center New Orleans, and colleagues has discovered a new mutation in a gene that causes Schnyder corneal dystrophy (SCD.)
› Verified 1 days ago